Literature DB >> 28456488

Secondary syphilis mimicking malignancy: A case report and review of literature.

Claudio Cerchione1, Alberto Enrico Maraolo2, Luana Marano3, Novella Pugliese3, Davide Nappi3, Grazia Tosone2, Ilaria Cimmino4, Imma Cozzolino4, Vincenzo Martinelli3, Fabrizio Pane3, Marco Picardi5.   

Abstract

A 56-year-old man developed disseminate lymphadenopathies, associated with hepato-splenomegaly, fever, nocturnal sweating and weight loss. Imaging studies in particular FDG-PET/CT raised the suspicion of a malignant disease. But blood flow cytometry assay for B/T cell clonality was negative and fine-needle biopsy of enlarged laterocervical lymph node showed a not specific "reactive hyperplasia". Four months later, the patient developed a non-itching rash; since a further anamnestic investigation revealed an history of high-risk sexual intercourse, the patient underwent serological tests for Treponema pallidum that were positive at high titer, after a first negative screening. Made the diagnosis of secondary syphilis, the patient responded to the treatment with benzyl penicillin with complete resolution of symptoms. This case highlights the importance of carefully screening the patients with suspected lymphoadenopathies also for lue, particularly in presence of behavioral risk factors.
Copyright © 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Lymphadenopathy; Lymphoma; Malignancy mimicking; Syphilis

Mesh:

Substances:

Year:  2017        PMID: 28456488     DOI: 10.1016/j.jiac.2017.03.003

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  1 in total

1.  Secondary Syphilis with Tonsillar and Cervical Lymphadenopathy and a Pulmonary Lesion Mimicking Malignant Lymphoma.

Authors:  Yukiko Komeno; Yasunori Ota; Tomohiko Koibuchi; Yoichi Imai; Kuniko Iihara; Tomiko Ryu
Journal:  Am J Case Rep       Date:  2018-03-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.